Ming-jen G. Lee
No. 7, Zhongshan S. Rd, 100
Zhongzheng Dist, TPQ, Taiwan
Zhongzheng Dist, TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Perfusion defects on thallium-201 scintigraphy in cardiac amyloidosis.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: September 24, 2025
Exploring Pembrolizumab-Induced IM3OS in a Patient With Bladder Cancer.
Journal: Pharmacology research & perspectives
Published: May 12, 2025
Machine learning to predict mitochondrial diseases by phenotypes.
Journal: Mitochondrion
Published: April 04, 2025
Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 17, 2025
Evaluating CAR-T cells from neurofibromatosis type 1 (NF1) patients for targeting AXL in malignant peripheral nerve sheath tumors associated with NF1.
Journal: British journal of cancer
Published: December 29, 2024
Recent Advancement of Neurofibromatosis Type 1: A Narrative Review.
Journal: Acta neurologica Taiwanica
Published: October 09, 2024
A consensus on the diagnosis and management of neurofibromatosis type 1 in Taiwan.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: October 01, 2024
Transthyretin variants impact blood-nerve barrier and neuroinflammation in amyloidotic neuropathy.
Journal: Brain : a journal of neurology
Published: August 13, 2024
Impact of Tafamidis on [99mTc]Tc-pyrophosphate Scintigraphy in Ala97Ser Hereditary Transthyretin amyloid cardiomyopathy: significant initial reduction with stable Long-Term effects.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 01, 2024
Use of technetium-99m-pyrophosphate single-photon emission computed tomography/computed tomography in monitoring therapeutic changes of RNA interference therapeutics in patients with hereditary transthyretin amyloid cardiomyopathy.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: July 22, 2024
Use of Technetium-99m-Pyrophosphate Single-Photon Emission Computed Tomography/Computed Tomography in Monitoring Therapeutic Changes of Eplontersen in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy.
Journal: Journal of the American Heart Association
Published: January 12, 2024
Last Updated: 09/26/2026